Catalyst Wire Dossier Catalyst Wire Dossier

QAK423A

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QAK423A, covering 2010-09-17 to 2010-09-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of QAK423A in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 1]

See pricing